Gender-Related Differences in Clinical and Pathological Characteristics and Therapy of Bladder Cancer
- 31 January 2003
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 43 (1) , 53-62
- https://doi.org/10.1016/s0302-2838(02)00496-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- INTRAVESICAL INSTILLATION OF EPIRUBICIN, BACILLUS CALMETTE-GUERIN AND BACILLUS CALMETTE-GUERIN PLUS ISONIAZID FOR INTERMEDIATE AND HIGH RISK TA, T1 PAPILLARY CARCINOMA OF THE BLADDER: A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITO-URINARY GROUP RANDOMIZED PHASE III TRIALJournal of Urology, 2001
- Epidemiology of Bladder CancerEuropean Urology, 1999
- The prognostic role of gender in survival of adult cancer patientsEuropean Journal Of Cancer, 1998
- Epidemiology and etiology of bladder cancerSeminars in Surgical Oncology, 1997
- Bladder cancer incidence and survival in the south-eastern part of the Netherlands, 1975–1989European Journal Of Cancer, 1994
- Prognostic factors in pTa‐pT1 superficial bladder tumours treated with intravesical instillationsBritish Journal of Urology, 1994
- The association of bladder cancer risk with ethnicity, gender, and smokingAnnals of Epidemiology, 1993
- Unexplained Excess Risk of Bladder Cancer in MenJNCI Journal of the National Cancer Institute, 1990
- Should pT1 Transitional Cell Cancers of the Bladder still be Classified as Superficial?British Journal of Urology, 1988
- The Copenhagen case-control study of bladder cancer: role of smoking in invasive and non-invasive bladder tumours.Journal of Epidemiology and Community Health, 1987